Transcription Factor |
Target ORF/Genes |
References |
Evidence Code |
Evidence Experiment |
Association Type |
Strain |
Environmental Condition |
Pdr3p
|
YDR011W
|
PubMed
Mahé Y et al., Mol Microbiol, 1996 Apr;20(1):109-17Mahé Y et al., Mol Microbiol, 1996 Apr;20(1):109-17 |
N/A |
|
N/A |
S288c |
N/A |
PubMed
Cui Z et al., Mol Microbiol, 1998 Sep;29(5):1307-15Cui Z et al., Mol Microbiol, 1998 Sep;29(5):1307-15 |
Indirect |
Northern blot - wt vs TF mutant |
Positive |
S288c |
YPD medium; mid-log phase |
PubMed
DeRisi J et al., FEBS Lett, 2000 Mar 24;470(2):156-60DeRisi J et al., FEBS Lett, 2000 Mar 24;470(2):156-60 |
Indirect |
Microarray analysis - wt vs TF mutant |
Positive |
FY1679-28C/TDEC |
Cells in exponential-phase in SC medium expressing Pdr1 and Pdr3 hyperactive alleles |
PubMed
Devaux F et al., FEBS Lett, 2002;():Devaux F et al., FEBS Lett, 2002;(): |
Indirect |
Microarray analysis - wt vs TF mutant |
Positive |
FY1679-28C / SEY6210 |
Mitochondrial dysfunction; rho0 petites grown in YPD medium to exponential phase |
Indirect |
Microarray analysis - wt vs TF mutant |
Positive |
FY1679-28C |
Rho+ cells not expressing PDR3 or expressing PDR3-7 gain-of-function allele grown in YPD medium to exponential phase |
PubMed
Wehrschütz-Sigl E et al., Eur J Biochem, 2004 Mar;271(6):1145-52Wehrschütz-Sigl E et al., Eur J Biochem, 2004 Mar;271(6):1145-52 |
N/A |
|
N/A |
S288c |
N/A |
PubMed
Onda M et al., Gene, 2004;():Onda M et al., Gene, 2004;(): |
Indirect |
Microarray analysis - wt vs TF mutant |
Positive |
S288c |
YPGal + Adenine |
PubMed
Banerjee D et al., Eukaryot Cell, 2008 Jan;7(1):68-77Banerjee D et al., Eukaryot Cell, 2008 Jan;7(1):68-77 |
Indirect |
Microarray analysis - wt vs TF mutant |
N/A |
S288c |
N/A |
PubMed
Kolaczkowska A et al., FEBS Lett, 2008 Mar 19;582(6):977-83Kolaczkowska A et al., FEBS Lett, 2008 Mar 19;582(6):977-83 |
Indirect |
Northern blot - wt vs TF mutant |
Positive |
S288c |
SC medium; mid-log phase |
PubMed
Salin H et al., BMC Genomics, 2008 Jul 15;0(0):33Salin H et al., BMC Genomics, 2008 Jul 15;0(0):33 |
Indirect |
Microarray analysis - wt vs TF mutant |
Negative |
BY4742 |
YPD |
Indirect |
Microarray analysis - wt vs TF mutant |
Negative |
BY4742 |
YPD+1mM selenite 40 min |
Indirect |
Microarray analysis - wt vs TF mutant |
Negative |
BY4742 |
YPD+1mM selenite 60 min |
Indirect |
Microarray analysis - wt vs TF mutant |
Positive |
BY4742 |
YPD+1mM selenite 80 min |
PubMed
Hazelwood LA et al., Appl Environ Microbiol, 2010 Jan;76(1):318-28Hazelwood LA et al., Appl Environ Microbiol, 2010 Jan;76(1):318-28 |
Indirect |
Microarray analysis - wt vs TF mutant |
Positive |
CEN.PK113-5D |
0.2 g.l-1 hop iso-ALFA-acids, |
PubMed
Ling H et al., Biotechnol Biofuels, 2015;():Ling H et al., Biotechnol Biofuels, 2015;(): |
Indirect |
RT-PCR - wt vs TF mutant |
Positive |
S288c |
0.5 g/l galactose + 1% C10 alkane |
PubMed
Vanacloig-Pedros E et al., J Biol Chem, 2019 Aug 30;294(35):12933-12946Vanacloig-Pedros E et al., J Biol Chem, 2019 Aug 30;294(35):12933-12946 |
Indirect |
Luciferase - wt vs TF mutant |
Positive |
BY4741 |
SD-His medium + 1 h with 50 uM citrinin |
PubMed
Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314Rossi MJ et al., Nature, 2021 Apr;592(7853):309-314 |
Direct |
ChIP-exo |
N/A |
BY4741 |
YPD medium, 25.C |